HeMemics Biotechnologies, Inc.


Hememics Biotechnologies is transforming the future of diagnostics with breakthrough monolayer graphene technology. Their innovative, pocket-sized reader and advanced multiplexed-sensor chips deliver precise results for small-molecule and protein tests in just five minutes, even in the toughest environments. Serving markets such as drug testing, agriculture, biodefense, and emergency diagnostics, Hememics aims to be the 'Intel Inside' of graphene-based sensor technology, making advanced healthcare and biosecurity more accessible through cost-effective, disposable sensors that eliminate the need for expensive silicon fabrication.

Industries

biotechnology
health-care
health-diagnostics
medical-device

Nr. of Employees

small (1-50)

HeMemics Biotechnologies, Inc.

1 Professional Drive, Suite 220, Gait, Hersburg, MD 20879-3445


Patents

Preservation solutions for biologics and methods related thereto

US-9943075-B2

View Details

Desiccated biologics and methods of preparing the same

US-9642353-B2

View Details

Desiccated biologics and methods of preparing the same

US-8628960-B2

View Details

Products

Handheld multiplexed biosensor reader

Portable reader that interfaces with single-use multiplexed biochips, performs signal acquisition and analysis, stores results locally, and transmits data via Bluetooth.

Single-use multiplexed disposable biochip (multi-sensor)

Disposable biochip containing multiple individually programmed sensors for simultaneous detection of small molecules, proteins, antigens, and molecular targets.

Laboratory benchtop analyzer for multiplexed biochips

Bench instrument intended to operate with multiplexed disposable biochips for elevated laboratory testing and analysis.

Dry-preservation reagent solution for biosensors

A desiccation-based preservation solution and process used to stabilize biological reagents and bioreceptor layers for dry-storage on disposable sensors.


Services

Design and deployment of multiplexed assays for specific target panels and application areas.

Collaborative arrangements to scale production capacity for graphene-based disposable sensors.

Expertise Areas

  • Point-of-care diagnostics
  • Multiplexed biosensing
  • Graphene-based sensor development
  • Aptamer-based assay development
  • Show More (4)

Key Technologies

  • Monolayer graphene sensors
  • Aptamer bioreceptors
  • Multiplexed disposable biochips
  • Polymer-based sensor fabrication
  • Show More (4)

News & Updates

Hememics showcased their products at the Anaheim Convention Center, CA, from July 23 to July 27, Booth #951.

Hememics Biotechnologies, Inc. announced the successful close of a $2 million seed 2 financing round from TEDCO and qualified investors to accelerate growth.

Hememics Biotechnologies, Inc. and General Graphene Corporation cemented a strategic partnership for large-scale production of graphene-based biosensors.

Successfully closed a $2 million seed 2 financing round to support growth and development.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.